Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57,233 | 50 | 66.5% |
| Food and Beverage | $17,306 | 787 | 20.1% |
| Travel and Lodging | $10,896 | 14 | 12.7% |
| Consulting Fee | $435.85 | 3 | 0.5% |
| Education | $192.73 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SCPHARMACEUTICALS INC. | $19,107 | 14 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $17,482 | 37 | $0 (2024) |
| Esperion Therapeutics, Inc. | $12,328 | 49 | $0 (2024) |
| Daiichi Sankyo Inc. | $8,576 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $4,897 | 37 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,882 | 46 | $0 (2024) |
| Ancora Heart, Inc. | $2,861 | 18 | $0 (2024) |
| Lilly USA, LLC | $2,275 | 6 | $0 (2021) |
| Medtronic, Inc. | $1,494 | 6 | $0 (2023) |
| Amgen Inc. | $1,356 | 81 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,405 | 164 | SCPHARMACEUTICALS INC. ($8,455) |
| 2023 | $28,911 | 223 | SCPHARMACEUTICALS INC. ($10,652) |
| 2022 | $19,290 | 217 | Bayer HealthCare Pharmaceuticals Inc. ($11,532) |
| 2021 | $21,459 | 258 | Esperion Therapeutics, Inc. ($9,436) |
All Payment Transactions
862 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.04 | General |
| Category: Cardiovascular | ||||||
| 12/18/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $5.49 | General |
| Category: Medical Device | ||||||
| 12/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $7.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: Cardiology | ||||||
| 12/02/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Cardio-renal | ||||||
| 11/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $131.94 | General |
| Category: Coronary | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/18/2024 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | Ancora Heart, Inc. | AccuCinch (Device) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $33.83 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/13/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: Cardiology | ||||||
| 11/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $30.86 | General |
| Category: Not Applicable | ||||||
| 11/06/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $34.62 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,776 | 3,393 | $591,473 | $132,076 |
| 2022 | 20 | 1,758 | 3,336 | $567,038 | $123,647 |
| 2021 | 22 | 1,800 | 3,330 | $588,661 | $128,981 |
| 2020 | 21 | 1,817 | 3,150 | $575,840 | $114,489 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 542 | 1,213 | $383,308 | $87,479 | 22.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 108 | 288 | $63,072 | $13,988 | 22.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $21,296 | $3,892 | 18.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 502 | 801 | $20,025 | $3,715 | 18.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 49 | 49 | $20,188 | $3,488 | 17.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 258 | 343 | $4,502 | $2,840 | 63.1% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2023 | 16 | 63 | $8,442 | $2,017 | 23.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 17 | 121 | $10,090 | $1,985 | 19.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 41 | 117 | $12,051 | $1,944 | 16.1% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 21 | 120 | $9,908 | $1,940 | 19.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 23 | 24 | $7,728 | $1,709 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $6,848 | $1,616 | 23.6% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 28 | 48 | $5,136 | $1,512 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 22 | $4,686 | $1,185 | 25.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $6,699 | $1,178 | 17.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 27 | 43 | $5,044 | $969.55 | 19.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 24 | 26 | $1,482 | $364.25 | 24.6% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 15 | 22 | $638.00 | $161.92 | 25.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 15 | 22 | $330.00 | $92.40 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 541 | 1,187 | $375,092 | $84,113 | 22.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 96 | 276 | $60,444 | $12,446 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $21,296 | $4,039 | 19.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 501 | 807 | $20,175 | $3,731 | 18.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 32 | $13,184 | $2,714 | 20.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $12,180 | $2,520 | 20.7% |
About Stephen Miller, ACNP
Stephen Miller, ACNP is a Acute Care healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851381198.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephen Miller, ACNP has received a total of $86,064 in payments from pharmaceutical and medical device companies, with $16,405 received in 2024. These payments were reported across 862 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($57,233).
As a Medicare-enrolled provider, Miller has provided services to 7,151 Medicare beneficiaries, totaling 13,209 services with total Medicare billing of $499,193. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Knoxville, TN
- Active Since 10/27/2005
- Last Updated 09/21/2020
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1851381198
Products in Payments
- FUROSCIX (Drug) $19,107
- Kerendia (Drug) $17,482
- NEXLIZET (Drug) $11,841
- INJECTAFER (Drug) $8,576
- JARDIANCE (Drug) $7,172
- FARXIGA (Drug) $4,395
- AccuCinch (Device) $2,861
- Repatha (Biological) $1,351
- LifeVest (Device) $1,195
- Reveal LINQ (Device) $1,050
- Barostim Neo System (Device) $1,034
- XARELTO (Drug) $1,023
- ELIQUIS (Drug) $730.64
- ENTRESTO (Drug) $655.93
- LEQVIO (Drug) $551.03
- NEXLETOL (Drug) $487.32
- VYNDAQEL (Drug) $420.11
- BRILINTA (Drug) $329.02
- Edarbyclor (Drug) $321.96
- CardioMEMS HF System (Device) $307.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Knoxville
Mr. Timothy Ballard, Acnp, ACNP
Acute Care — Payments: $43,500
Kimberly Smith, Apn, APN
Acute Care — Payments: $13,176
Dr. William Stafford, Agacnp, AGACNP
Acute Care — Payments: $4,313
Mrs. Shelley Lott, Arnp, ARNP
Acute Care — Payments: $4,000
Mrs. Frankie Cate, Acnp-Bc, ACNP-BC
Acute Care — Payments: $3,165
Kerry Hastey-Witt, Aprn, APRN
Acute Care — Payments: $2,905